| Variable |
Frequency |
Percent (%) |
| Immunization (n=347) |
|
|
| Appropriate for age |
294 |
84.7 |
| Not appropriate for age |
41 |
11.8 |
| Not immunized |
12 |
3.4 |
| Nutritional history (n=248) |
|
|
| Exclusive Breastfeeding only |
83 |
33.4 |
| Replacement only |
11 |
4.4 |
| Mixed Breastfeeding |
154 |
62.1 |
| Infant prophylaxis (n=189) |
|
|
| None |
171 |
90.4 |
| sdNVP |
7 |
3.7 |
| sdNVP + AZT |
7 |
3.7 |
| Cotrimoxazol prophylaxis |
|
|
| Yes |
420 |
75.0 |
| No |
140 |
25.0 |
| ART Adherence on follow up (n=512) |
|
|
| Good |
494 |
96.5 |
| Fair |
8 |
1.5 |
| Poor |
10 |
2.0 |
| Absolute CD4 count |
|
|
| CD4 count above threshold |
207 |
37.2 |
| CD4 count below threshold |
349 |
62.7 |
| Hemoglobin (n=522) |
|
|
| ≥ 10 gm/dl |
413 |
79.1 |
| < 10 gm/dl |
109 |
20.9 |
| WHO clinical staging |
|
|
| Stage I |
59 |
10.5 |
| Stage II |
101 |
18.0 |
| Stage III |
330 |
59.0 |
| Stage IV |
69 |
12.5 |
| Nutritional status |
|
|
| Under weight |
289 |
51.6 |
| Normal |
266 |
47.4 |
| Over weight |
5 |
1.0 |
| Developmental milestone (n=537) |
|
|
| Appropriate |
458 |
85.3 |
| Delayed |
63 |
11.7 |
| Regressed |
16 |
3.0 |
| Opportunistic Infections on follow up |
|
|
| Yes |
171 |
34.0 |
| No |
333 |
66.0 |
| ART drug side effect during follow up |
|
|
| Yes |
38 |
7.0 |
| No |
522 |
93.0 |
| Previous PTB |
|
|
| Yes |
85 |
15.0 |
| No |
475 |
85.0 |
